192 related articles for article (PubMed ID: 10339482)
1. Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells).
Bao H; Jacobs-Helber SM; Lawson AE; Penta K; Wickrema A; Sawyer ST
Blood; 1999 Jun; 93(11):3757-73. PubMed ID: 10339482
[TBL] [Abstract][Full Text] [Related]
2. Activation of the Akt/FKHRL1 pathway mediates the antiapoptotic effects of erythropoietin in primary human erythroid progenitors.
Uddin S; Kottegoda S; Stigger D; Platanias LC; Wickrema A
Biochem Biophys Res Commun; 2000 Aug; 275(1):16-9. PubMed ID: 10944433
[TBL] [Abstract][Full Text] [Related]
3. The death-promoting activity of p53 can be inhibited by distinct signaling pathways.
Lin Y; Brown L; Hedley DW; Barber DL; Benchimol S
Blood; 2002 Dec; 100(12):3990-4000. PubMed ID: 12393587
[TBL] [Abstract][Full Text] [Related]
4. Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells.
Sakamoto H; Kitamura T; Yoshimura A
J Biol Chem; 2000 Nov; 275(46):35857-62. PubMed ID: 10960479
[TBL] [Abstract][Full Text] [Related]
5. Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway.
Santos SC; Lacronique V; Bouchaert I; Monni R; Bernard O; Gisselbrecht S; Gouilleux F
Oncogene; 2001 Apr; 20(17):2080-90. PubMed ID: 11360192
[TBL] [Abstract][Full Text] [Related]
6. A novel role for STAT1 in regulating murine erythropoiesis: deletion of STAT1 results in overall reduction of erythroid progenitors and alters their distribution.
Halupa A; Bailey ML; Huang K; Iscove NN; Levy DE; Barber DL
Blood; 2005 Jan; 105(2):552-61. PubMed ID: 15213094
[TBL] [Abstract][Full Text] [Related]
7. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.
Bouscary D; Pene F; Claessens YE; Muller O; Chrétien S; Fontenay-Roupie M; Gisselbrecht S; Mayeux P; Lacombe C
Blood; 2003 May; 101(9):3436-43. PubMed ID: 12506011
[TBL] [Abstract][Full Text] [Related]
8. Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways.
Sui X; Krantz SB; Zhao ZJ
Br J Haematol; 2000 Jul; 110(1):63-70. PubMed ID: 10930980
[TBL] [Abstract][Full Text] [Related]
9. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
Tong W; Zhang J; Lodish HF
Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
[TBL] [Abstract][Full Text] [Related]
10. A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction.
Kashii Y; Uchida M; Kirito K; Tanaka M; Nishijima K; Toshima M; Ando T; Koizumi K; Endoh T; Sawada K; Momoi M; Miura Y; Ozawa K; Komatsu N
Blood; 2000 Aug; 96(3):941-9. PubMed ID: 10910908
[TBL] [Abstract][Full Text] [Related]
11. Association of JAK2 and STAT5 with erythropoietin receptors. Role of receptor phosphorylation in erythropoietin signal transduction.
Sawyer ST; Penta K
J Biol Chem; 1996 Dec; 271(50):32430-7. PubMed ID: 8943308
[TBL] [Abstract][Full Text] [Related]
12. JNK and p38 are activated by erythropoietin (EPO) but are not induced in apoptosis following EPO withdrawal in EPO-dependent HCD57 cells.
Jacobs-Helber SM; Ryan JJ; Sawyer ST
Blood; 2000 Aug; 96(3):933-40. PubMed ID: 10910907
[TBL] [Abstract][Full Text] [Related]
13. Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation.
Erickson-Miller CL; Pelus LM; Lord KA
Stem Cells; 2000; 18(5):366-73. PubMed ID: 11007921
[TBL] [Abstract][Full Text] [Related]
14. TEL-Syk fusion constitutively activates PI3-K/Akt, MAPK and JAK2-independent STAT5 signal pathways.
Kanie T; Abe A; Matsuda T; Kuno Y; Towatari M; Yamamoto T; Saito H; Emi N; Naoe T
Leukemia; 2004 Mar; 18(3):548-55. PubMed ID: 14749700
[TBL] [Abstract][Full Text] [Related]
15. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
[TBL] [Abstract][Full Text] [Related]
16. The signaling pathways of erythropoietin and interferon-gamma differ in preventing the apoptosis of mature erythroid progenitor cells.
Paiboonsukwong K; Choi I; Matsushima T; Abe Y; Nishimura J; Winichagoon P; Fucharoen S; Nawata H; Muta K
Int J Hematol; 2003 Dec; 78(5):421-8. PubMed ID: 14704034
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2.
Kilic U; Kilic E; Soliz J; Bassetti CI; Gassmann M; Hermann DM
FASEB J; 2005 Feb; 19(2):249-51. PubMed ID: 15556972
[TBL] [Abstract][Full Text] [Related]
18. Activated STAT5 proteins induce activation of the PI 3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding adapter.
Nyga R; Pecquet C; Harir N; Gu H; Dhennin-Duthille I; Régnier A; Gouilleux-Gruart V; Lassoued K; Gouilleux F
Biochem J; 2005 Aug; 390(Pt 1):359-66. PubMed ID: 15833084
[TBL] [Abstract][Full Text] [Related]
19. Phosphatase inhibition promotes antiapoptotic but not proliferative signaling pathways in erythropoietin-dependent HCD57 cells.
Lawson AE; Bao H; Wickrema A; Jacobs-Helber SM; Sawyer ST
Blood; 2000 Sep; 96(6):2084-92. PubMed ID: 10979952
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines.
Silva M; Benito A; Sanz C; Prosper F; Ekhterae D; Nuñez G; Fernandez-Luna JL
J Biol Chem; 1999 Aug; 274(32):22165-9. PubMed ID: 10428780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]